DoP asks NPPA to review, verify Bharat Serum and Vaccine's
The Department of Pharmaceuticals (DoP) has issued an order disposing the review application of Bharat Serum and Vaccine (BSVL) to the National Pharmaceutical Pricing Authority (NPPA) instructing to verify the applicability of GST factor by cross-checking the documents submitted by BSVL pertaining to the formulation Human Normal Immunoglobulin.
DoP asks NPPA to reconsider retail price fixation on Abbott’s
The DoP took up the matter and examined the argument from both the sides, before arriving at a decision to remand the review petition to the NPPA. Abbott, in its review application said that the NPPA fixed the retail price for the formulation based on recommendations of the Multi Disciplinary Committee (MDC) of Experts, using the average of
DoP asks NPPA to review, verify Bharat Serum and Vaccine’s
You are here: Industry Insights > Market News > DoP asks NPPA to review, ... Hot Products. L-Arginine . 2,3,4,5,6-Pentafluorobromobenzene. Zeaxanthin(Marigold Extract)
DoP clarifies on NPPA’s price-capping powers, under PMO
Under Para 31, of DPCO, 2013, DoP can review the orders of NPPA and in such case the government orders prevail. The OMs (office memoradums) referred by you are review orders by the government (DoP) under Para 31 of DPCO, 2013 and not be treated as setting limits to powers of NPPA,” Singh told The Indian Express.
DoP junks Skymap Pharma review plea against NPPA
Subsequently, DoP rejected the review application while noting; "The retail price of Fluconazole Tablets 300mg was fixed vide SO 4103(E), dated 14.11.2025 by strictly following the provisions in para 5 of DPCO. Hence, the present review application is not sustainable and stands rejected." for more details click on the link below-
